Beijing Beilu Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -3.67% vs 15.29% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -6.10% vs 293.60% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "320.40",
          "val2": "332.60",
          "chgp": "-3.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "48.30",
          "val2": "40.10",
          "chgp": "20.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.40",
          "val2": "2.60",
          "chgp": "30.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.80",
          "val2": "48.20",
          "chgp": "-94.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "46.20",
          "val2": "49.20",
          "chgp": "-6.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "150.70%",
          "val2": "43.50%",
          "chgp": "10.72%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 22.52% vs 10.25% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 29,433.33% vs 100.36% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,197.40",
          "val2": "977.30",
          "chgp": "22.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "181.70",
          "val2": "150.40",
          "chgp": "20.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "40.10",
          "val2": "58.50",
          "chgp": "-31.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "53.50",
          "val2": "-12.50",
          "chgp": "528.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "88.60",
          "val2": "0.30",
          "chgp": "29,433.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "66.00%",
          "val2": "51.50%",
          "chgp": "1.45%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

320.40

332.60

-3.67%

Operating Profit (PBDIT) excl Other Income

48.30

40.10

20.45%

Interest

3.40

2.60

30.77%

Exceptional Items

2.80

48.20

-94.19%

Consolidate Net Profit

46.20

49.20

-6.10%

Operating Profit Margin (Excl OI)

150.70%

43.50%

10.72%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -3.67% vs 15.29% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -6.10% vs 293.60% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,197.40

977.30

22.52%

Operating Profit (PBDIT) excl Other Income

181.70

150.40

20.81%

Interest

40.10

58.50

-31.45%

Exceptional Items

53.50

-12.50

528.00%

Consolidate Net Profit

88.60

0.30

29,433.33%

Operating Profit Margin (Excl OI)

66.00%

51.50%

1.45%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 22.52% vs 10.25% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 29,433.33% vs 100.36% in Dec 2024

All Annual Results